{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:31:35Z","timestamp":1793889095636,"version":"4.8.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Transthyretin amyloidosis (ATTR amyloidosis) is a progressive, multi-systemic disease with wild-type (ATTRwt) and hereditary (ATTRv) forms. Over 130 variants associated with ATTRv amyloidosis have been identified, although little is known about the majority of these genotypes. This analysis examined phenotypic characteristics of symptomatic patients with ATTRv amyloidosis enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS) with four less frequently reported pathogenic genotypes: F64L (c.250T&gt;C, p.F84L), I68L (c.262A&gt;T, p.I88L), I107V (c.379A&gt;G; p.I127V), and S77Y (c.290C&gt;A; p.S97Y). THAOS is the largest ongoing, global, longitudinal observational study of patients with ATTR amyloidosis, including both ATTRwt and ATTRv amyloidosis. This analysis describes the baseline demographic and clinical characteristics of untreated symptomatic patients with the F64L, I68L, I107V, or S77Y genotypes at enrollment in THAOS (data cutoff date: January 4, 2022). There were 141 symptomatic patients with F64L (n = 46), I68L (n = 45), I107V (n = 21), or S77Y (n = 29) variants at the data cutoff. Most patients were male and median age at enrollment was in the sixth decade for S77Y patients and the seventh decade for the others. A predominantly neurologic phenotype was associated with F64L, I107V, and S77Y genotypes, whereas patients with the I68L genotype presented with more pronounced cardiac involvement. However, a mixed phenotype was also reported in a considerable proportion of patients in each variant subgroup. This analysis from THAOS represents the largest study of ATTRv symptomatic patients with the F64L, I68L, I107V, and S77Y genotypes. These data add to the limited knowledge on the clinical profile of patients with specific ATTRv variants and emphasize the importance of comprehensive assessment of all patients.<\/jats:p>\n<jats:p>Trial registration<\/jats:p>\n<jats:p>ClinicalTrials.gov: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00628745\" xlink:type=\"simple\">NCT00628745<\/jats:ext-link>.<\/jats:p>","DOI":"10.1371\/journal.pone.0292435","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T18:31:56Z","timestamp":1705689116000},"page":"e0292435","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS)"],"prefix":"10.1371","volume":"19","author":[{"given":"Luca","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3823-3809","authenticated-orcid":true,"given":"Igor","family":"Diemberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Plante-Bordeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Dori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-505X","authenticated-orcid":true,"given":"Marco","family":"Luigetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Paolantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia","family":"Waddington Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Inamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnt V.","family":"Kristen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Lino Cirami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritam","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Amass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"issue":"22","key":"pone.0292435.ref001","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"FL Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"pone.0292435.ref002","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"V Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"issue":"7","key":"pone.0292435.ref003","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"D Adams","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"pone.0292435.ref004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Y Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"pone.0292435.ref005","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","volume":"268","author":"D Adams","year":"2021","journal-title":"J Neurol"},{"issue":"10","key":"pone.0292435.ref006","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"FL Ruberg","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"pone.0292435.ref007","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ehf2.12518","article-title":"Transthyretin cardiac amyloidosis: an update on diagnosis and treatment","volume":"6","author":"H Yamamoto","year":"2019","journal-title":"ESC Heart Fail"},{"key":"pone.0292435.ref008","author":"D Rowczenio","year":"2015","journal-title":"Mutations in Hereditary Amyloidosis"},{"issue":"4","key":"pone.0292435.ref009","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/13506129.2020.1794807","article-title":"ATTRv amyloidosis Italian Registry: clinical and epidemiological data","volume":"27","author":"M Russo","year":"2020","journal-title":"Amyloid"},{"issue":"4","key":"pone.0292435.ref010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1529-8027.2012.00436.x","article-title":"Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset","volume":"17","author":"M Russo","year":"2012","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"pone.0292435.ref011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13023-019-1000-1","article-title":"Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series","volume":"14","author":"M Waddington-Cruz","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"s2","key":"pone.0292435.ref012","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.3233\/JND-150091","article-title":"Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in Sicily, an Italian endemic area","volume":"2","author":"A Mazzeo","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"pone.0292435.ref013","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/eurheartj\/ehz173","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"43","author":"T Damy","year":"2019","journal-title":"Eur Heart J"},{"issue":"10","key":"pone.0292435.ref014","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ejhf.1285","article-title":"Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure","volume":"20","author":"C Gagliardi","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"pone.0292435.ref015","doi-asserted-by":"crossref","first-page":"104524","DOI":"10.1016\/j.ejmg.2022.104524","article-title":"Involvement of cranial nerves in ATTR Ile127Val amyloidosis","volume":"65","author":"JAD Silva Batista","year":"2022","journal-title":"Eur J Med Genet"},{"issue":"1\u20132","key":"pone.0292435.ref016","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-510X(02)00051-5","article-title":"Transthyretin Val 107 in a Japanese patient with familial amyloid polyneuropathy","volume":"198","author":"K Nanri","year":"2002","journal-title":"J Neurol Sci"},{"issue":"3","key":"pone.0292435.ref017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1529-8027.2008.00185.x","article-title":"Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin","volume":"13","author":"J Cassereau","year":"2008","journal-title":"J Peripher Nerv Syst"},{"issue":"9","key":"pone.0292435.ref018","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neurol.2021.02.392","article-title":"Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France","volume":"177","author":"JB Davion","year":"2021","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"pone.0292435.ref019","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.24519","article-title":"Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France","volume":"78","author":"LL Mariani","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"pone.0292435.ref020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1185\/03007995.2012.754349","article-title":"The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology","volume":"29","author":"V Plante-Bordeneuve","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"pone.0292435.ref021","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mus.25257","article-title":"Clinical measures in transthyretin familial amyloid polyneuropathy","volume":"55","author":"T Coelho","year":"2017","journal-title":"Muscle Nerve"},{"issue":"8","key":"pone.0292435.ref022","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","article-title":"United States valuation of EQ-5D-5L health states using an international protocol","volume":"22","author":"AS Pickard","year":"2019","journal-title":"Value Health"},{"issue":"1","key":"pone.0292435.ref023","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13023-022-02359-w","article-title":"Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update","volume":"17","author":"A Dispenzieri","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"pone.0292435.ref024","first-page":"662","article-title":"Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy","volume":"14","author":"L Leibou","year":"2012","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"pone.0292435.ref025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/13506120701815373","article-title":"Gender-related risk of myocardial involvement in systemic amyloidosis","volume":"15","author":"C Rapezzi","year":"2008","journal-title":"Amyloid"},{"issue":"3","key":"pone.0292435.ref026","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp-2017-316657","article-title":"mtDNA copy number associated with age of onset in familial amyloid polyneuropathy","volume":"89","author":"D Santos","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T18:32:12Z","timestamp":1705689132000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292435"}},"subtitle":[],"editor":[{"given":"Maria","family":"Gasset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0292435","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}